References

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

10.1161/str.0000000000000024 · 2014 · External reference

Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial

10.1016/s1474-4422(18)30195-9 · 2018 · External reference

Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial

10.1016/s1474-4422(12)70159-x · 2012 · External reference

Cumulative incidence of restenosis in the endovascular treatment of extracranial carotid artery stenosis: a meta-analysis

10.1136/neurintsurg-2018-014534 · 2019 · External reference

Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study

10.1161/01.cir.94.6.1247 · 1996 · External reference

Predictors of restenosis after successful carotid artery stenting

10.1016/s0002-9149(03)00912-3 · 2003 · External reference

Preprocedural neutrophil to albumin ratio predicts in-stent restenosis following carotid angioplasty and stenting

10.1016/j.jstrokecerebrovasdis.2019.06.027 · 2019 · External reference

Severe, recurrent in-stent carotid restenosis: endovascular approach, risk factors. Results from a prospective academic registry of 2637 consecutive carotid artery stenting procedures (TARGET-CAS)

2019 · External reference

Neutrophil to lymphocyte ratio as a predictor of restenosis after angioplasty and stenting for asymptomatic carotid stenosis

10.1177/0003319718784805 · 2019 · External reference

In-stent restenosis is associated with neointimal angiogenesis and macrophage infiltrates

10.1016/j.prp.2014.04.004 · 2014 · External reference

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

10.1016/j.jhep.2023.06.003 · 2023 · External reference

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

10.1136/gutjnl-2023-330595 · 2024 · External reference

Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease

10.1007/s12072-021-10167-w · 2021 · External reference

The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque

10.1186/s12872-023-03580-6 · 2023 · External reference

The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China

10.1186/s12872-025-04491-4 · 2025 · External reference

FIB-4 index and neutrophil-to-lymphocyte-ratio as death predictor in coronary artery disease patients

10.3390/biomedicines11010076 · 2022 · External reference

Liver fibrosis and the risk of coronary artery disease, stent thrombosis, restenosis and adverse clinical outcomes

10.1111/apt.70306 · 2026 · External reference

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators

10.1056/nejm199811123392002 · 1998 · External reference

Preprocedural carotid plaque echolucency as a predictor of in-stent intimal restenosis after carotid artery stenting

10.1016/j.jstrokecerebrovasdis.2020.105339 · 2020 · External reference

Periprocedural cilostazol treatment and restenosis after carotid artery stenting: the retrospective study of In-stent restenosis after carotid artery stenting (ReSISteR-CAS)

10.1016/j.jstrokecerebrovasdis.2010.06.007 · 2012 · External reference

Association between liver fibrosis and risk of incident stroke and mortality: a large prospective cohort study

10.1161/jaha.125.042025 · 2025 · External reference

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

10.1002/hep.32665 · 2023 · External reference

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

10.1002/hep.21178 · 2006 · External reference

Grading carotid intrastent restenosis: a 6-year follow-up study

10.1161/strokeaha.107.497487 · 2008 · External reference

Randomized controlled trial of cilostazol addition for in-stent restenosis after carotid artery stenting

10.1161/strokeaha.124.047210 · 2024 · External reference

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study

10.1186/s12933-020-01064-x · 2020 · External reference

Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease

10.1016/j.jhep.2023.04.002 · 2023 · External reference

Fetuin-A: a relevant novel serum biomarker for non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective case-control study

10.1186/s12876-024-03310-y · 2024 · External reference

Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus

10.1016/j.jdiacomp.2016.11.006 · 2017 · External reference

Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects

10.1111/liv.12478 · 2015 · External reference

Platelet functional profile is altered in metabolic dysfunction-associated steatotic liver disease

10.1111/liv.70231 · 2025 · External reference

Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury

10.1161/01.cir.103.20.2501 · 2001 · External reference

Platelet activation and atherothrombosis

10.1056/nejmra071014 · 2007 · External reference

Mean platelet volume as a biomarker for liver fibrosis in patients with non-alcoholic fatty liver disease

10.1371/journal.pone.0318847 · 2025 · External reference

Exploring the pathogenesis and immunological profiles of psoriasis complicated with MASLD

10.1371/journal.pone.0305217 · 2024 · External reference

Inflammation in liver fibrosis and atrial fibrillation: a prospective population-based proteomic study

2024 · External reference

Recent update on the anti-inflammatory activities of Propolis

10.3390/molecules27238473 · 2022 · External reference